Stocks/BATL

BATL three-lens brief

Evidence-based stock research on BATL. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 08:00 ET
$1.00$1.37$29.70

Performance

1W
+5.4%
1M
+0.7%
3M
6M
YTD
1Y
3Y
5Y
BATL · Nightly brief
Concern

50-day MA below 200-day MA (death-cross regime); price below both. · Trading at 1% of its 52-week range — deep in the lower band.

  • Trading at 1% of its 52-week range — deep in the lower band.
  • 50-day MA below 200-day MA (death-cross regime); price below both.
  • Underperforming SPY by 13.8pp over 30 days.
  • P/E of 0.9 — trading at a value multiple.
  • Negative free cash flow last quarterly (-$8.47M).

BATL closed at $1.37 (+0.74%) as of 2026-09-11. Market cap: $78.48M. P/E (trailing) 0.9. Price is below the 50-day MA and below the 200-day MA. Positives: p/E of 0.9 — trading at a value multiple.. Concerns: trading at 1% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $54.27M, net income -$4.75M, free cash flow -$8.47M.

Market ✓· Fundamentals ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on BATL, not one.

A single reasoning model has blind spots it doesn’t know about. We examine BATLacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/BATL"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath BATL brief"></iframe>